Troponin Rapid Tests and Point of Care (POC) - Medical Devices Pipeline Assessment, 2020

Troponin Rapid Tests and Point of Care (POC) - Medical Devices Pipeline Assessment, 2020

Summary

The publisher's Medical Devices sector report, “Troponin Rapid Tests and Point of Care (POC) - Medical Devices Pipeline Assessment, 2020 " provides comprehensive information about the Troponin Rapid Tests & Point of Care (POC) pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Troponin Rapid Tests & POC are point-of-care diagnostic tests enables to measure troponin levels specific to cardiovascular diseases in patient’s sample.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

Extensive coverage of the Troponin Rapid Tests & Point of Care (POC) under development
The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
The report reviews the major players involved in the development of Troponin Rapid Tests & Point of Care (POC) and list all their pipeline projects
The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
The report provides key clinical trial data of ongoing trials specific to pipeline products
Recent developments in the segment / industry

Reasons to Buy

The report enables you to -

Formulate significant competitor information, analysis, and insights to improve R&D strategies
Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
Identify and understand important and diverse types of Troponin Rapid Tests & Point of Care (POC) under development
Develop market-entry and market expansion strategies
Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
In-depth analysis of the product’s current stage of development, territory and estimated launch date

1 Table of Contents

1.1 List of Tables
1.2 List of Figures

2 Introduction

2.1 Troponin Rapid Tests & POC Overview

3 Products under Development

3.1 Troponin Rapid Tests & POC - Pipeline Products by Stage of Development
3.2 Troponin Rapid Tests & POC - Pipeline Products by Territory
3.3 Troponin Rapid Tests & POC - Pipeline Products by Regulatory Path
3.4 Troponin Rapid Tests & POC - Pipeline Products by Estimated Approval Date

4 Troponin Rapid Tests & POC - Pipeline Products under Development by Companies

4.1 Troponin Rapid Tests & POC Companies - Pipeline Products by Stage of Development
4.2 Troponin Rapid Tests & POC - Pipeline Products by Stage of Development

5 Troponin Rapid Tests & POC Companies and Product Overview

5.1 Abbott Point of Care Inc Company Overview
5.2 Angle Biosciences Inc Company Overview
5.3 Anteo Technologies Pty Ltd Company Overview
5.4 BBB Technologies Inc Company Overview
5.5 Bio-AMD Inc Company Overview
5.6 Carclo Diagnostic Solutions Ltd Company Overview
5.7 Group K Diagnostics Company Overview
5.8 MML Ltd Company Overview
5.9 Nanomix Inc Company Overview
5.10 Ohmx Corp Company Overview
5.11 OPKO Health Inc Company Overview
5.12 Resdin Technologies Inc. Company Overview
5.13 Sandia National Laboratories Company Overview
5.14 SpinChip Diagnostics AS Company Overview

6 Troponin Rapid Tests & POC- Recent Developments

6.1 Feb 26, 2020: bioMerieux - 2019 financial results
6.2 Oct 22, 2019: bioMerieux - Third quarter 2019 business review
6.3 Sep 04, 2019: bioMerieux announces First-Half 2019 Results

7 Appendix

7.1 Methodology
7.2 About the Publisher
7.3 Contact
7.4 Disclaimer

List of Tables

Table 1: Troponin Rapid Tests & POC - Pipeline Products by Stage of Development
Table 2: Troponin Rapid Tests & POC - Pipeline Products by Territory
Table 3: Troponin Rapid Tests & POC - Pipeline Products by Regulatory Path
Table 4: Troponin Rapid Tests & POC - Pipeline Products by Estimated Approval Date
Table 5: Troponin Rapid Tests & POC Companies - Pipeline Products by Stage of Development
Table 6: Troponin Rapid Tests & POC - Pipeline Products by Stage of Development
Table 7: Abbott Point of Care Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 8: i-STAT TnI-Nx - Product Status
Table 9: i-STAT TnI-Nx - Product Description
Table 10: Angle Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 11: Cardiac Troponin Biomarker Kit - Product Status
Table 12: Cardiac Troponin Biomarker Kit - Product Description
Table 13: Anteo Technologies Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 14: AtomoRapid - Heart Attack - Product Status
Table 15: AtomoRapid - Heart Attack - Product Description
Table 16: BBB Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 17: markB - cTnl Test - Product Status
Table 18: markB - cTnl Test - Product Description
Table 19: Mobile RDT Reader - Troponin-I Test - Product Status
Table 20: Mobile RDT Reader - Troponin-I Test - Product Description
Table 21: Bio-AMD Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 22: Magnetic Immunoassay Detection System - Cardiac Troponin - Product Status
Table 23: Magnetic Immunoassay Detection System - Cardiac Troponin - Product Description
Table 24: Carclo Diagnostic Solutions Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 25: Micropoc-pro - Troponin-I Assay - Product Status
Table 26: Micropoc-pro - Troponin-I Assay - Product Description
Table 27: Group K Diagnostics Pipeline Products & Ongoing Clinical Trials Overview
Table 28: Multidiagnostic - Troponin T And I Test - Product Status
Table 29: Multidiagnostic - Troponin T And I Test - Product Description
Table 30: MML Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 31: MIDS Cardiac - Troponin Test - Product Status
Table 32: MIDS Cardiac - Troponin Test - Product Description
Table 33: Nanomix Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 34: eLab Critical Cardiac Test - Product Status
Table 35: eLab Critical Cardiac Test - Product Description
Table 36: Ohmx Corp Pipeline Products & Ongoing Clinical Trials Overview
Table 37: Diagnostic Assay - hs Troponin I - Product Status
Table 38: Diagnostic Assay - hs Troponin I - Product Description
Table 39: Portable POC System - hs Troponin I - Product Status
Table 40: Portable POC System - hs Troponin I - Product Description

List of Figures

Figure 1: Troponin Rapid Tests & POC - Pipeline Products by Stage of Development
Figure 2: Troponin Rapid Tests & POC - Pipeline Products by Territory
Figure 3: Troponin Rapid Tests & POC - Pipeline Products by Regulatory Path
Figure 4: Troponin Rapid Tests & POC - Pipeline Products by Estimated Approval Date